Federal Register Notice
Premerger Notification; Reporting and Waiting Period Requirements; Notice of Extension of Public Comment Period
Date
Displaying 101 - 120 of 1605
FTC and DOJ Extend Public Comment Period by 30 Days on Proposed Changes to HSR Form
Date
The Federal Trade Commission and Department of Justice’s Antitrust Division are extending by 30 days the deadline for the public to submit comments on proposed changes to the premerger notification...
Statement Regarding Termination of CooperCompanies’ Attempted Acquisition of Cook Medical’s Reproductive Health Business
Date
The Federal Trade Commission has learned that the Cooper Companies Inc. has terminated its $875 million acquisition of Cook Medical Holdings, LLC’s reproductive health business. In response, FTC...
Statement Of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines
Date
By
Rebecca Kelly Slaughter, Commissioner
Matter Number
P234000
FTC and DOJ Seek Comment on Draft Merger Guidelines
Date
Today, the Federal Trade Commission and the Department of Justice are releasing a draft update of the Merger Guidelines, which describe and guide the agencies’ review of mergers and acquisitions to...
FTC Sues to Block IQVIA’s Acquisition of Propel Media to Prevent Increased Concentration in Health Care Programmatic Advertising
Date
The Federal Trade Commission is seeking to block IQVIA Holdings Inc. (IQVIA), the world’s largest health care data provider, from acquiring Propel Media, Inc. (PMI), alleging in an administrative...
Altria Group/JUUL Labs, In the Matter of
The Federal Trade Commission filed an administrative complaint alleging that Altria Group, Inc. and JUUL Labs, Inc. entered a series of agreements, including Altria’s acquisition of a 35% stake in JUUL, that eliminated competition in violation of federal antitrust laws. According to the complaint, this series of agreements involved Altria ceasing to compete in the U.S. market for closed-system electronic cigarettes in return for a substantial ownership interest in JUUL, by far the dominant player in that market. In an initial decision announced on Feb. 24, 2022, Chief Administrative Law Judge D. Michael Chappell dismissed the antitrust charges in the complaint.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
191 0075
Docket Number
9393
Case Status
Closed
Federal Register Notice
16 CFR Parts 801 and 803: Premerger Notification; Reporting and Waiting Period Requirements
Date
Q and A on the Notice of Proposed Rulemaking for the HSR Filing Process
FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review
Date
The Federal Trade Commission, with the concurrence of the Assistant Attorney General of the Antitrust Division of the U.S. Department of Justice, is proposing changes to the premerger notification...
FTC Policy Director Issues Statement Commending Maine’s Repeal of Certificate of Public Advantage Law
Date
The Federal Trade Commission has learned that the state of Maine recently enacted legislation repealing the state’s Hospital and Health Care Provider Cooperation Act , which allowed for certain...
FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement
Date
In a comment to North Carolina House Health Committee members, the Federal Trade Commission staff opposed a bill pending before the state legislature attempting to prevent antitrust authorities from...
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Date
The Federal Trade Commission and the U.S. Department of Justice, Antitrust Division released a summary of a two-day workshop that explored new approaches to enforcement of the antitrust laws in the...
Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.
Date
In response to the announcement that Boston Scientific Corporation and non-vascular stent manufacturer M.I. Tech Co., Ltd. have terminated their $230 million purchase agreement, Federal Trade...
Amgen Inc. and Horizon Therapeutics plc, FTC v.
Type of Action
Federal
Last Updated
FTC Matter/File Number
231 0037
Case Status
Pending
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
Date
The Federal Trade Commission is seeking to block biopharmaceutical giant Amgen Inc. from acquiring Horizon Therapeutics plc, saying the deal would allow Amgen to leverage its portfolio of blockbuster...
Displaying 101 - 120 of 1605